The global Life Sciences Customer Relationship Management (CRM) market is witnessing robust growth, valued at USD 1.24 billion in 2024, expected to reach USD 1.32 billion in 2025, and projected to grow to USD 2.29 billion by 2034. With a steady CAGR of 6.32% from 2025 to 2034, this sector is driven by digital-first engagement, AI integration, personalized medicine, and increasing demand for value-based care.
This article offers a deep dive into the segmental and regional insights of the market and highlights the leading companies shaping the life sciences CRM landscape.
2024 Market Size: USD 1.24 billion
Forecast for 2034: USD 2.29 billion
CAGR (2025–2034): 6.32%
North America: Dominated the market with a 45% revenue share in 2024.
Asia Pacific: Poised for the fastest growth over the forecast period.
Sales Force Automation (SFA): Held 39% market share in 2024.
Patient Engagement & Support Programs: Expected to register the fastest growth rate.
About: Veeva is a global leader in cloud-based software tailored to life sciences companies.
Products: Veeva CRM, Vault, and Commercial Cloud Suite.
Market Cap: Approx. USD 32 billion.
About: The world’s #1 CRM provider, Salesforce tailors solutions for healthcare and life sciences through Health Cloud.
Products: Salesforce Health Cloud, Einstein AI, and AppExchange integrations.
Market Cap: Approx. USD 270 billion.
About: A division of Oracle focused on data-driven clinical and commercial operations.
Products: Oracle Clinical One, Siebel CRM, and Oracle Health Sciences Cloud.
Market Cap: Approx. USD 350 billion.
About: IQVIA offers advanced analytics and technology solutions for life sciences.
Products: Orchestrated Customer Engagement, OCE CRM, and real-world evidence platforms.
Market Cap: Approx. USD 47 billion.
About: Microsoft’s CRM and ERP solutions tailored to healthcare provider and life sciences workflows.
Products: Dynamics 365 Sales, Customer Insights, and Healthcare Accelerator.
Market Cap: Approx. USD 3.5 trillion.
About: Zinfi focuses on Unified Channel Management and partner relationship tools.
Products: CRM for Life Sciences, Partner Relationship Management (PRM).
Market Cap: Privately held (undisclosed).
About: A Swiss company providing mobile CRM solutions for field teams in life sciences.
Products: Pitcher Super App for commercial excellence and sales enablement.
Market Cap: Privately held (undisclosed).
About: ACTO offers an AI-powered commercial learning platform for life sciences.
Products: ACTO Omnichannel Education Platform, CRM connectors.
Market Cap: Privately held (undisclosed).
About: Known for quote-to-cash automation and CLM software, supporting life sciences sales teams.
Products: Conga CRM integration, Apttus CPQ, CLM.
Market Cap: Privately held, post-merger with Conga (valued around USD 715 million).
About: Offers Salesforce-optimized CRM tools for verticals including life sciences.
Products: Sforce CRM extensions and life sciences modules.
Market Cap: Not publicly available.
About: A global SaaS company offering user-friendly CRM for SMEs and enterprises.
Products: Freshsales, Freshmarketer for life sciences field reps.
Market Cap: Approx. USD 3 billion.
About: French-based provider of healthcare-focused CRM and data solutions.
Products: Mobile Intelligence, OneKey database, and marketing automation tools.
Market Cap: Approx. USD 500 million.
About: A digital-first commercialization company focused on healthcare.
Products: CRM, omnichannel marketing, medical content platforms.
Market Cap: Estimated at USD 1 billion (private company).
About: A biopharmaceutical solutions company offering integrated life sciences services.
Products: Field deployment CRM, commercialization strategy tools.
Market Cap: Acquired by a private equity consortium in 2023 (deal valued at USD 7.1 billion).
About: A global consulting firm with strong life sciences CRM capabilities.
Products: CRM consulting, analytics platforms, and sales optimization tools.
Market Cap: Private partnership (est. revenue over USD 1 billion).
About: An India-based company offering industry-specific CRM platforms.
Products: CRM for Pharma Sales, Doctor engagement, distributor management.
Market Cap: Privately held (undisclosed).
About: Specializes in mobile sales force automation and CRM for consumer goods and life sciences.
Products: TouchRx, StayinFront EdgeRx.
Market Cap: Private company (global operations).
About: Specializes in medication safety analytics integrated with healthcare CRM.
Products: Data-driven CRM for pharmacy and hospital systems.
Market Cap: Privately held startup (early-stage growth).
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
Life sciences CRM (Customer Relationship Management) systems manage interactions with healthcare professionals, patients, and stakeholders. It supports commercial operations, regulatory compliance, and patient engagement in pharma, biotech, and medical device sectors.
It facilitates drug launches, improves field sales productivity, ensures regulatory alignment, and enhances engagement through omnichannel strategies.
North America currently holds the largest share (~45%), driven by early tech adoption and strong healthcare infrastructure.
The Patient Engagement and Support Programs segment is expected to grow at the highest CAGR due to the increasing focus on personalized care and adherence.
Some of the top companies include Veeva Systems, Salesforce, Oracle, IQVIA, Microsoft, and Freshworks, along with several specialized providers like ACTO, Pitcher, and Cegedim.
Source : https://www.towardshealthcare.com/insights/life-sciences-crm-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5895
Asia-Pacific is poised to become the fastest-growing region in the small-scale bioreactors market over the coming years, driven by several… Read More
North America continues to dominate the global neurostimulation devices market, holding a significant 60% share in 2024. Several key factors… Read More
AAVnerGene Inc., an innovative biotech company based in Rockville, MD, known for its cutting-edge AAV tissue-targeted delivery and manufacturing technologies,… Read More
Jiangsu Hengrui Pharmaceuticals Co., Ltd. and IDEAYA Biosciences, Inc. are set to showcase their groundbreaking research at the IASLC 2025… Read More
QIAGEN has launched its new QIAseq xHYB long-read panels, a cutting-edge solution designed to explore the complexities of genomically diverse… Read More
Kyoto, Japan July 2025 A groundbreaking collaboration has been formed between Kansai Startup Academia Coalition (KSAC), led by Kyoto University,… Read More